Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| AbbVie (NYSE: ABBV) | Delayed: 285.64 +0.45 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $285.19 | 52 Week High | $68.12 | |||
| Open | $284.58 | 52 Week Low | $50.71 | |||
| Day High | $286.77 | P/E | 61.96 | |||
| Day Low | $282.30 | EPS | $4.61 | |||
| Volume | 4,631,852 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 250.69 -3.15 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $253.84 | 52 Week High | $333.65 | |||
| Open | $251.68 | 52 Week Low | $223.02 | |||
| Day High | $252.44 | P/E | 32.10 | |||
| Day Low | $246.15 | EPS | $7.81 | |||
| Volume | 1,157,377 | |||||
